Novartis AG
METHODS AND COMPOSITIONS FOR DIAGNOSING, TREATING, AND MONITORING TREATMENT OF SHANK3 DEFICIENCY ASSOCIATED DISORDERS
Last updated:
Abstract:
The invention provides novel methods and compositions for diagnosing, treating, and monitoring treatment of Shank3 (SH3 and multiple ankyrin repeat domains 3) deficiency associated disorders.
Status:
Application
Type:
Utility
Filling date:
10 Sep 2020
Issue date:
24 Dec 2020